New research suggests popular GLP-1 drugs like Wegovy and Mounjaro could significantly reduce the need for knee replacement surgery in arthritis patients.
Jill Biden's new memoir reveals doctors checked on the former president moments after his troubled debate performance, contradicting earlier White House statements.
Shocking documents reveal maternity staff used derogatory codes to dismiss vulnerable pregnant women, exposing a deeply troubling culture within one of the NHS's most scrutinized trusts.
The largest maternity inquiry in NHS history exposes shocking failures at Nottingham hospitals — but the story goes far deeper than individual misconduct.
When Craig was diagnosed with terminal bladder cancer, his one wish was to die at home. Fulfilling that wish cost his wife over $65,000.
A groundbreaking mRNA vaccine tailored to each patient's tumor is showing impressive five-year results when paired with immunotherapy drug Keytruda.
Sudden cardiac death isn't just a risk for athletic young men. UK researchers reveal that routine heart checks are uncovering hidden dangers in thousands of young women.
The WHO director general has called for unified community involvement to combat the worsening Ebola outbreak in the DRC, now entering alarming new territory.
A alarming new report warns the world is hurtling toward a catastrophic cancer workforce crisis, with a projected shortfall of 100 million healthcare workers by 2050.
The UK government says sharing NHS patient records across providers could prevent 20,000 A&E visits and save £20m every year.
A groundbreaking drug called daraxonrasib has shown the ability to double survival time in advanced pancreatic cancer patients, with experts calling it a historic gamechanger.
A new experimental drug called daraxonrasib has nearly doubled survival time in advanced pancreatic cancer patients, offering the first major leap forward in decades.